SCHEMBL18201201

SCHEMBL18201201

c1cc(-c2ccc(-c3nc(-c4cc5ccccc5c5ccccc45)cc(-c4cc5ccccc5c5ccccc45)n3)cc2)cc(-c2nc3ccccc3c3c2ccc2ccccc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
ATM Q13315 2/20 0.37
MAPT P10636 7/20 0.36
LMNA P02545 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
RECQL P46063 1/20 0.36
ALDH1A1 P00352 5/20 0.36
HPGD P15428 5/20 0.36
KDM4E B2RXH2 5/20 0.36
HTT P42858 2/20 0.35
NPY1R P25929 1/20 0.35
NPY2R P49146 1/20 0.35
PTGES O14684 1/20 0.34
CYP11B1 P15538 1/20 0.33
POLB P06746 1/20 0.33
HSP90AA1 P07900 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200836 0.96 MEN1 (0.37) MEN1KMT2AATMMAPTLMNA
SCHEMBL18200510 0.95 MAPT (0.37) MEN1KMT2AATMMAPTLMNA
SCHEMBL18200739 0.94 MAPT (0.38) MEN1KMT2AATMMAPTLMNA
SCHEMBL18201117 0.94 MAPT (0.39) MAPTLMNASMN1; SMN2NPC1RAB9A
SCHEMBL18200414 0.93 MEN1 (0.40) MEN1KMT2AATMMAPTLMNA
SCHEMBL22607088 0.92 MAPT (0.37) MEN1KMT2AATMMAPTLMNA
SCHEMBL18200446 0.92 ATM (0.40) MEN1KMT2AATMMAPTLMNA
SCHEMBL18201147 0.92 MEN1 (0.41) MEN1KMT2AATMMAPTLMNA
SCHEMBL18201288 0.91 ALDH1A1 (0.37) MEN1KMT2AATMMAPTLMNA
SCHEMBL18200430 0.91 ALDH1A1 (0.38) MEN1KMT2AMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MEN1 1750/4885KMT2A 1104/4885ATM 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.